affiliation not provided to SSRN
Uterine Neoplasm, Endometrial cancer, molecular classification, Immunohistochemistry, Surgery.
Endometrial Cancer, HER2, Trastuzumab deruxtecan, T-DXd, DS-8201a, Antibody-drug conjugate